ENDRA Life Sciences (NDRA) Invested Capital (2016 - 2026)

ENDRA Life Sciences (NDRA) has 11 years of Invested Capital data on file, last reported at $1.8 million in Q1 2026.

• Invested Capital for Q1 2026 came in at $1.8 million, up 1.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (up 1.94% YoY), and the FY2025 annual result was $2.3 million, down 11.73% from the prior year.
• Invested Capital declined to $1.8 million in Q1 2026 per NDRA's latest filing, from $2.3 million in the prior quarter.
• Over five years, Invested Capital peaked at $13.8 million in Q2 2022 and troughed at $171380.0 in Q3 2025.
• A 5-year average of $5.5 million and a median of $5.2 million in 2023 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2024 and 2025: Invested Capital rose 26.41% in 2024, then plunged 97.41% in 2025.
• A 5-year view of Invested Capital shows it stood at $7.2 million in 2022, then retreated by 21.45% to $5.7 million in 2023, then tumbled by 54.76% to $2.6 million in 2024, then retreated by 11.73% to $2.3 million in 2025, then declined by 20.94% to $1.8 million in 2026.
• Business Quant data shows NDRA's Invested Capital at $1.8 million in Q1 2026, $2.3 million in Q4 2025, and $171380.0 in Q3 2025.